Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
|
Outline of Final Research Achievements |
This study was performed to investigate the impact of galectin-1 in metastasis of renal cell carcinoma (RCC). Human RCC-derived ACHN cell line showed a significant increased migration after treatment with galectin-1, which may be mediated by regulation of the cytoskeletal dynamics. Meanwhile, we observed no effect of endogenous galectin-1 on RCC cell lines migration and invasion. This study suggests that galectin-1 can be considered as a target of suppression and prevention for metastasis of RCC.
|